Potential clinical applications of chelating drugs in diseases targeting transferrin-bound iron and other metals
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Potential clinical applications of chelating drugs in diseases targeting transferrin-bound iron and other metals
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 22, Issue 5, Pages 591-618
Publisher
Informa Healthcare
Online
2013-04-16
DOI
10.1517/13543784.2013.787408
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Toward optimizing the use of deferasirox: potential benefits of combined use with deferoxamine
- (2012) R. W. Grady et al. HAEMATOLOGICA
- Effect of deferiprone, an oral iron chelator, in diabetic and non-diabetic glomerular disease
- (2012) Mohan M. Rajapurkar et al. TOXICOLOGY MECHANISMS AND METHODS
- Is Deferasirox Implicated in Multiple Organ Failure in a Patient With Homozygous β-Thalassemia?
- (2011) Efthimia Vlachaki et al. ANGIOLOGY
- Regulation of cellular iron metabolism
- (2011) Jian Wang et al. BIOCHEMICAL JOURNAL
- Oral chelators in transfusion-dependent thalassemia major patients may prevent or reverse iron overload complications
- (2011) Kallistheni Farmaki et al. BLOOD CELLS MOLECULES AND DISEASES
- Efficacy, Compliance And Toxicity Factors Are Affecting The Rate Of Normalization Of Body Iron Stores In Thalassemia Patients Using The Deferiprone And Deferoxamine Combination Therapy
- (2011) Annita Kolnagou et al. HEMOGLOBIN
- Interactions Of Hydroxycarbamide (Hydroxyurea) With Iron And Copper: Implications On Toxicity and Therapeutic Strategies
- (2011) Eleni Konstantinou et al. HEMOGLOBIN
- A Record Of 1320 Suspect, Deferasirox-Related, Patient Deaths Reported In 2009: Insufficient Toxicity Testing, Low Efficacy And Lack Of Transparency May Endanger The Lives Of Iron Loaded Patients
- (2011) George J. Kontoghiorghes HEMOGLOBIN
- The iron redox and hydrolysis chemistry of the ferritins
- (2010) Fadi Bou-Abdallah BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- The effect of deferasirox on cardiac iron in thalassemia major: impact of total body iron stores
- (2010) J. C. Wood et al. BLOOD
- Combined Therapy with Idebenone and Deferiprone in Patients with Friedreich’s Ataxia
- (2010) Daniel Velasco-Sánchez et al. CEREBELLUM
- Variation in iron accumulation, transferrin membrane binding and DNA synthesis in the K-562 and U-937 cell lines induced by chelators and their iron complexes
- (2010) Klas Forsbeck et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Reduction of body iron stores to normal range levels in thalassaemia by using a deferiprone/deferoxamine combination and their maintenance thereafter by deferiprone monotherapy
- (2010) Annita Kolnagou et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Safety issues of iron chelation therapy in patients with normal range iron stores including thalassaemia, neurodegenerative, renal and infectious diseases
- (2010) G J Kontoghiorghes et al. Expert Opinion On Drug Safety
- Maintenance of Normal Range Body Iron Store Levels for up to 4.5 Years in Thalassemia Major Patients Using Deferiprone Monotherapy
- (2010) Annita Kolnagou et al. HEMOGLOBIN
- The Role of Iron and Chelators on Infections in Iron Overload and Non Iron Loaded Conditions: Prospects for the Design of New Antimicrobial Therapies
- (2010) George J. Kontoghiorghes et al. HEMOGLOBIN
- Acquired Proximal Renal Tubular Dysfunction in β-Thalassemia Patients Treated With Deferasirox
- (2010) Joanne Yacobovich et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Fanconi Syndrome Due to Deferasirox
- (2009) Cédric Rafat et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Hyperchloremic Metabolic Acidosis Due to Deferasirox in a Patient with Beta Thalassemia Major
- (2009) Nikolaos Papadopoulos et al. ANNALS OF PHARMACOTHERAPY
- Iron Accumulation in the Substantia Nigra of Patients With Alzheimer Disease and Parkinsonism
- (2009) Sonia Brar et al. ARCHIVES OF NEUROLOGY
- Normalisation of total body iron load with very intensive combined chelation reverses cardiac and endocrine complications of thalassaemia major
- (2009) Kallistheni Farmaki et al. BRITISH JOURNAL OF HAEMATOLOGY
- Improved survival in thalassemia major patients on switching from desferrioxamine to combined chelation therapy with desferrioxamine and deferiprone
- (2009) P. T. Telfer et al. HAEMATOLOGICA
- Advances in the Prevention and Treatment are Changing Thalassemia from a Fatal to a Chronic Disease. Experience from a Cyprus Model and its Use as a Paradigm for Future Applications
- (2009) Anita Kolnagou et al. HEMOGLOBIN
- Risk/Benefit Assessment, Advantages Over Other Drugs and Targeting Methods in the Use of Deferiprone as a Pharmaceutical Antioxidant in Iron Loading and Non Iron Loading Conditions
- (2009) George J. Kontoghiorghes et al. HEMOGLOBIN
- A New Era in Iron Chelation Therapy: The Design of Optimal, Individually Adjusted Iron Chelation Therapies for the Complete Removal of Iron Overload in Thalassemia and other Chronically Transfused Patients
- (2009) George J. Kontoghiorghes HEMOGLOBIN
- The Unique Kinetics of Iron Release from Transferrin: The Role of Receptor, Lobe–Lobe Interactions, and Salt at Endosomal pH
- (2009) Shaina L. Byrne et al. JOURNAL OF MOLECULAR BIOLOGY
- The ins and outs of mitochondrial iron-loading: the metabolic defect in Friedreich’s ataxia
- (2009) Des R. Richardson et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Iron availability and infection
- (2008) Eugene D. Weinberg BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Pharmacokinetics, Distribution, Metabolism, and Excretion of Deferasirox and Its Iron Complex in Rats
- (2008) G. J. M. Bruin et al. DRUG METABOLISM AND DISPOSITION
- Development of lens opacities with peculiar characteristics in patients affected by thalassemia major on chelating treatment with deferasirox (ICL670) at the Pediatric Clinic in Monza, Italy
- (2008) N. Masera et al. HAEMATOLOGICA
- Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders
- (2008) E. Angelucci et al. HAEMATOLOGICA
- Myocyte Damage and Loss of Myofibers is the Potential Mechanism of Iron Overload Toxicity in Congestive Cardiac Failure in Thalassemia. Complete Reversal of the Cardiomyopathy and Normalization of Iron Load by Deferiprone
- (2008) Annita Kolnagou et al. HEMOGLOBIN
- Chelators Controlling Metal Metabolism and Toxicity Pathways: Applications in Cancer Prevention, Diagnosis and Treatment
- (2008) George J. Kontoghiorghes et al. HEMOGLOBIN
- Long Term Comparative Studies in Thalassemia Patients Treated with Deferoxamine or a Deferoxamine/Deferiprone Combination. Identification of Effective Chelation Therapy Protocols
- (2008) Annita Kolnagou et al. HEMOGLOBIN
- Lactoferrin: structure, function and applications
- (2008) Susana A. González-Chávez et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- MRI assessment of basal ganglia iron deposition in Parkinson's disease
- (2008) Lauren I. Wallis et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Regression of symptoms after selective iron chelation therapy in a case of neurodegeneration with brain iron accumulation
- (2008) Gian Luca Forni et al. MOVEMENT DISORDERS
- Clinically Proven Radiopharmaceuticals for Infection Imaging: Mechanisms and Applications
- (2008) Stanley J. Goldsmith et al. SEMINARS IN NUCLEAR MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation